# Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions

> **NCT05524389** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 624 (estimated)

## Conditions studied

- Endometrial Cancer
- Adjuvant Radiotherapy
- Molecular Classification

## Interventions

- **RADIATION:** Vaginal brachytherapy
- **RADIATION:** Pelvic external beam radiotherapy
- **OTHER:** Observation
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT05524389
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-12-01
- **Primary completion:** 2026-12-01
- **Final completion:** 2027-06-30
- **Target enrollment:** 624 (ESTIMATED)
- **Last updated:** 2022-11-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05524389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05524389, "Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05524389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*